TOLUCOMBI

This brand name is authorized in Austria, Croatia, Estonia, Finland, Germany, Ireland, Italy, Lithuania, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug TOLUCOMBI contains a combination of these active pharmaceutical ingredients (APIs):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOLUCOMBI 40mg/12.5mg / 80mg/12.5mg Tablet	MPI, EU: SmPC	European Medicines Agency (EU)
TOLUCOMBI 80 mg/25 mg Tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA07	Telmisartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	10299885, 10299891, 10299916, 10299922, 10299939, 10299945, 10299974, 10299980, 10299997
EE	Ravimiamet	1609589, 1609590, 1609602, 1609613, 1609624, 1609635, 1609646, 1609657, 1609668, 1609679, 1609680, 1609691, 1609703, 1609714, 1609725, 1609736, 1609747, 1609758, 1609769, 1609770, 1609781, 1609792, 1609804, 1609815, 1664726, 1664737, 1664748
ES	Centro de información online de medicamentos de la AEMPS	113821004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	381868, 391984, 428658, 476392, 484388, 515151
GB	Medicines & Healthcare Products Regulatory Agency	245733, 245735, 245737
IE	Health Products Regulatory Authority	61075, 61132, 61453
IT	Agenzia del Farmaco	042715045, 042715146, 042715247
LT	Valstybinė vaistų kontrolės tarnyba	1069357, 1069745, 1069746, 1069747, 1069748, 1069749, 1069750, 1069751, 1069752, 1069753, 1069754, 1069755, 1069756, 1069757, 1069758, 1069759, 1069760, 1069761, 1069762, 1069763, 1069764, 1069765, 1069766, 1069767, 1069768, 1069769, 1069770, 1069771, 1069772, 1069773, 1076140, 1076141, 1076142
PL	Rejestru Produktów Leczniczych	100295015, 100295050, 100295067
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59819001, W59819002, W59819003, W59819004, W59819005, W59819006, W59819007, W59819008, W59819009, W59819010
SG	Health Sciences Authority	15616P, 15617P